Accepting new patients

Steven Raman, MD

  • Interventional Radiology|
  • Diagnostic Radiology
Westwood Imaging Center & Interventional Radiology Clinic | 100 Medical Plaza, Suite 100, Los Angeles, CA 90095


Director of Prostate MR Imaging and Interventions and UCLA Prostate MR Imaging Research Group

Dr. Raman is an expert in Abdominal and Pelvic imaging (CT, MRI, Ultrasound and X-Ray) and interventional radiology (image guided procedures), especially in the area of tumor ablation and Fibroid Treatment. He is also director of the Abdominal Imaging Fellowship at UCLA, and co-director of the Fibroid Treatment Program at UCLA.


English, Spanish


Medical Board Certification

Diagnostic Radiology, American Board of Radiology, 1998


Radiological Sciences, UCLA School of Medicine, 1999


Radiological Sciences, UCSD School of Medicine, 1998


Internal Medicine, Pacific Presbyterian Medical Center, 1994


MD, Keck School of Medicine of the USC, 1993


Hospital Affiliations

Ronald Reagan UCLA Medical Center

UCLA Santa Monica Medical Center


Meet Steven Raman, MD
State of the Art Diagnosis and Minimally Invasive Treatment of Liver, Kidney and Prostate Cancer



  • MRI Imaging of Prostate, Liver, Kidney and Gynecological Cancers
  • Thermal Ablation of Liver, Kidney, Adrenal Soft tissue, Gynecological Cancers including microwave, cryo, HIFU and Irreversible Electroporation
  • Artificial Intelligence
  • Radiogenomics



  1. Coy H, Young JR, Douek ML, Brown MS, Sayre J, Raman SS. Qantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography. Abdom Radiol (NY). 2017 Mar 9. doi: 10.1007/s00261-017-1095-6. [Epub ahead of print] PMID: 28280876
  2. Young JR, Coy H, Douek M, Lo P, Sayre J, Pantuck AJ, Raman SS. Type 1 papillary renal cell carcinoma: differentiation from Type 2 papillary RCC on multiphasic MDCT. Abdom Radiol (NY). 2017 Mar 7. doi: 10.1007/s00261-017-1091-x. [Epub ahead of print] PMID: 28265706
  3. Lee MW, Raman SS, Asvadi NH, Siripongsakun S, Hicks RM, Chen J, Worakitsitisatorn A, McWilliams J, Tong MJ, Finn RS, Agopian VG, Busuttil RW, Lu DSK. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis. Hepatology. 2017 Feb 7. doi: 10.1002/hep.29098. [Epub ahead of print] PMID: 28170115
  4. Young JR, Coy H, Kim HJ, Douek M, Lo P, Pantuck AJ, Raman SS. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma. AJR Am J Roentgenol. 2017 Apr;208(4):812-819. doi: 10.2214/AJR.16.17152. Epub 2017 Jan 26.
  5. Kim YK, Lin WC, Sung K, Raman SS, Margolis D, Lim Y, Gu S, Lu D. Reducing Artifacts during Arterial Phase of Gadoxetate Disodium-enhanced MR Imaging: Dilution Method versus Reduced Injection Rate. Radiology. 2017 May;283(2):429-437. doi: 10.1148/radiol.2016160241. Epub 2016 Dec 15. PMID: 27977329
  6. Tan N, Lin WC, Khoshnoodi P, Asvadi NH, Yoshida J, Margolis DJ, Lu DS, Wu H, Sung KH, Lu DY, Huang J, Raman SS. In-Bore 3-T MR-guided Transrectal Targeted Prostate Biopsy: Prostate Imaging Reporting and Data System Version 2-based Diagnostic Performance for Detection of Prostate Cancer. Radiology. 2017 Apr;283(1):130-139. doi: 10.1148/radiol.2016152827. Epub 2016 Nov 18. PMID: 27861110
  7. Priester A, Natarajan S, Khoshnoodi P, Margolis DJ, Raman SS, Reiter RE, Huang J, Grundfest W, Marks LS. Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology. J Urol. 2017 Feb;197(2):320-326. doi: 10.1016/j.juro.2016.07.084. Epub 2016 Jul 30 PMID: 27484386
  8. Donin NM, Duarte S, Lenis AT, Caliliw R, Torres C, Smithson A, Strauss-Ayali D, Agmon-Gerstein Y, Malchi N, Said J, Raman SS, Holden S, Pantuck A, Belldegrun AS, Chamie K.Sustained-release Formulation of Mitomycin C to the Upper Urinary Tract Using a Thermosensitive Polymer: A Preclinical Study. Urology. 2017 Jan;99:270-277. doi: 10.1016/j.urology.2016.09.039. Epub 2016 Oct 5. PMID: 27720772
  9. Brunsing RL, Schenker-Ahmed NM, White NS, Parsons JK, Kane C, Kuperman J, Bartsch H, Kader AK, Rakow-Penner R, Seibert TM, Margolis D, Raman SS, McDonald CR, Farid N, Kesari S, Hansel D, Shabaik A, Dale AM, Karow DS. Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI. J Magn Reson Imaging. 2017 Feb;45(2):323-336. doi: 10.1002/jmri.25419. Epub 2016 Aug 16. Review. PMID: 27527500
  10. Young JR, Coy H, Douek M, Lo P, Sayre J, Pantuck AJ, Raman SS. Clear cell renal cell carcinoma: identifying the gain of chromosome 12 on multiphasic MDCT.Abdom Radiol (NY). 2017 Jan;42(1):236-241. doi: 10.1007/s00261-016-0868-7. PMID: 27519835

See all publications (PDF)

In the News


  • Aetna
  • Anthem Blue Cross
  • Blue Shield of California
  • Centivo
  • Cigna
  • First Health
  • Health Net of California
  • Interplan (part of HealthSmart)
  • L.A. Care
  • MultiPlan
  • UFCM Health System
  • Prime Health Services
  • Private Healthcare Systems (PHCS)
  • UnitedHealthcare

The list of health care plans above may not be comprehensive and could change. 
Please contact your benefits coordinator or health insurance company directly to verify coverage.

Visit our health insurance information page for more details.


  • Super Doctors® Southern California, 2023, 2024
  • Top Doctors, Los Angeles Magazine, 2021
  • Best Doctor, 2021
  • Super Doctors® Southern California, 2017-2021
  • Leading Physicians of the World, 2021